Veramed

Data Monitoring Committees (DMCs) play a critical role in protecting patient safety and maintaining trial integrity. But establishing one involves more than appointing a committee and scheduling reviews. Successful implementation depends on early planning

From a single statistician to a large FSP team, Veramed has built a longstanding, trusted partnership with a large pharma sponsor over more than a decade. Initially, a single statistician supported early-phase, late-phase and rare disease studies. Over ti

Most small and mid-sized biotechs are deliberately built to be agile, with lean internal teams and flexible access to external expertise as needs evolve. This model enables organizations to manage cost, move quickly and bring in specialized capability wit

When designing a clinical trial, sponsors face countless decisions. One question that often arises, particularly in later-stage development or when planning interim analyses, is whether a Data Monitoring Committee (DMC) is needed. It's not always a straig

Through experienced DMC support, Veramed helped a sponsor navigate a highly complex Phase IIb study in non-alcoholic steatohepatitis (NASH), delivering interim analyses while simultaneously acting as a central coordination hub for unblinded data access. W

At the Young Statisticians' Meeting in Cambridge, Veramed statisticians Huw Wilson and Alice Fletcher presented their poster "Re-Randomization Tests in Clinical Trials: A Simulation Case Study & Practical Guidance." The poster explores how re-randomizatio

Veramed provided independent unblinded statistical support for multiple DMC deliveries for a large pharma client's Phase 2b double-blind, dose-ranging study and long-term extension. Through two proactive dry runs, granular internal time management and fle

Acquisitions can create exciting opportunities for sponsors, but they also bring immediate pressure to understand the quality, readiness, and regulatory defensibility of inherited clinical trial data.

A large pharmaceutical company needed to rapidly replace outsourced resources while reducing the management burden associated with traditional staff augmentation models. The client required a partner who could quickly build a high-quality team, take great

In this podcast, we explore how artificial intelligence is reshaping clinical research - not as a replacement for human expertise, but as a powerful enabler. Matthew Jones, EVP of Data Innovation & AI, together with Lacey Wallace, Manager, Programming, an